FDA health claims rulings may be subject of House Oversight hearing -- Rep. Burton.
This article was originally published in The Tan Sheet
Executive Summary
FDA HEALTH CLAIMS RULINGS "FLOUT" WILL OF CONGRESS, REP. BURTON asserts in an Aug. 13 letter to FDA Acting Commissioner Michael Friedman, MD. Rep. Dan Burton (R-Ind.), chairman of the House Government Reform & Oversight Committee, says FDA's position on the "authoritative statements" health and nutrient content claims provisions in the FDA Modernization Act "undo the good work" Congress has done in the health claims sections of the law. FDA issued nine interim final rules June 22 withholding approval of several proposed health claims included in notification letters filed with the agency by Salt Lake City- based Weider Nutrition International ("The Tan Sheet" June 29, pp. 1-9).
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning